Literature DB >> 8668551

Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers.

A Bielinska1, J F Kukowska-Latallo, J Johnson, D A Tomalia, J R Baker.   

Abstract

Starburst polyamidoamine (PAMAM) dendrimers are a new type of synthetic polymer characterized by a branched spherical shape and a high density surface charge. We have investigated the ability of these dendrimers to function as an effective delivery system for antisense oligonucleotides and 'antisense expression plasmids' for the targeted modulation of gene expression. Dendrimers bind to various forms of nucleic acids on the basis of electrostatic interactions, and the ability of DNA-dendrimer complexes to transfer oligonucleotides and plasmid DNA to mediate antisense inhibition was assessed in an in vitro cell culture system. Cell lines that permanently express luciferase gene were developed using dendrimer mediated transfection. Transfections of antisense oligonucleotides or antisense cDNA plasmids into these cell lines using dendrimers resulted in a specific and dose dependent inhibition of luciferase expression. This inhibition caused approximately 25-50% reduction of baseline luciferase activity. Binding of the phosphodiester oligonucleotides to dendrimers also extended their intracellular survival. While dendrimers were not cytotoxic at the concentrations effective for DNA transfer, some non-specific suppression of luciferase expression was observed. Our results indicate that Starburst dendrimers can be effective carriers for the introduction of regulatory nucleic acids and facilitate the suppression of the specific gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668551      PMCID: PMC145901          DOI: 10.1093/nar/24.11.2176

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Regulation of gene expression with double-stranded phosphorothioate oligonucleotides.

Authors:  A Bielinska; R A Shivdasani; L Q Zhang; G J Nabel
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

Review 2.  Oligonucleoside methylphosphonates as antisense reagents.

Authors:  P S Miller
Journal:  Biotechnology (N Y)       Date:  1991-04

3.  N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts.

Authors:  G W Krystal; B C Armstrong; J F Battey
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

4.  Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3'-terminus and their interaction with DNA within mammalian cells.

Authors:  A S Boutorin; L V Gus'kova; E M Ivanova; N D Kobetz; V F Zarytova; A S Ryte; L V Yurchenko; V V Vlassov
Journal:  FEBS Lett       Date:  1989-08-28       Impact factor: 4.124

5.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

6.  Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen.

Authors:  G Goodarzi; S C Gross; A Tewari; K Watabe
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

7.  Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.

Authors:  C F Bennett; M Y Chiang; H Chan; J E Shoemaker; C K Mirabelli
Journal:  Mol Pharmacol       Date:  1992-06       Impact factor: 4.436

8.  Homologous recombination of exogenous DNA fragments with genomic DNA in somatic cells of mice.

Authors:  M Gareis; P Harrer; W M Bertling
Journal:  Cell Mol Biol       Date:  1991       Impact factor: 1.770

9.  Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector.

Authors:  B J Roessler; J W Hartman; D K Vallance; J M Latta; S L Janich; B L Davidson
Journal:  Hum Gene Ther       Date:  1995-03       Impact factor: 5.695

10.  Antisense RNA complementary to 3' coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo.

Authors:  J L Ch'ng; R C Mulligan; P Schimmel; E W Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more
  47 in total

1.  Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor.

Authors:  Antonio Quintana; Ewa Raczka; Lars Piehler; Inhan Lee; Andrzej Myc; Istvan Majoros; Anil K Patri; Thommey Thomas; James Mulé; James R Baker
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 2.  Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection.

Authors:  Crispin R Dass
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

3.  Polycation-induced cell membrane permeability does not enhance cellular uptake or expression efficiency of delivered DNA.

Authors:  Lisa E Prevette; Douglas G Mullen; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 4.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

Review 5.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

6.  Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimers.

Authors:  Latha M Santhakumaran; Thresia Thomas; T J Thomas
Journal:  Nucleic Acids Res       Date:  2004-04-15       Impact factor: 16.971

7.  3H dendrimer nanoparticle organ/tumor distribution.

Authors:  Shraddha S Nigavekar; Lok Yun Sung; Mikel Llanes; Areej El-Jawahri; Theodore S Lawrence; Christopher W Becker; Lajos Balogh; Mohamed K Khan
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

8.  Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor.

Authors:  Andrew J Hollins; Mustapha Benboubetra; Yadollah Omidi; Bernd H Zinselmeyer; Andreas G Schatzlein; Ijeoma F Uchegbu; Saghir Akhtar
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

9.  Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratio.

Authors:  Alireza Nomani; Ismaeil Haririan; Ramin Rahimnia; Shamileh Fouladdel; Tarane Gazori; Rassoul Dinarvand; Yadollah Omidi; Ebrahim Azizi
Journal:  Int J Nanomedicine       Date:  2010-05-13

10.  Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.

Authors:  Moizza Mansoor; Alirio J Melendez
Journal:  Gene Regul Syst Bio       Date:  2008-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.